BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kain V, Ingle KA, Rajasekaran NS, Halade GV. Activation of EP4 receptor limits transition of acute to chronic heart failure in lipoxygenase deficient mice. Theranostics 2021;11:2742-54. [PMID: 33456570 DOI: 10.7150/thno.51183] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Luo Q, Ma H, Guo E, Yu L, Jia L, Zhang B, Feng G, Liu R. MicroRNAs Promote the Progression of Sepsis-Induced Cardiomyopathy and Neurovascular Dysfunction Through Upregulation of NF-kappaB Signaling Pathway-Associated HDAC7/ACTN4. Front Neurol 2022;13:909828. [PMID: 35756932 DOI: 10.3389/fneur.2022.909828] [Reference Citation Analysis]
2 Halade GV, Lee DH. Inflammation and resolution signaling in cardiac repair and heart failure. EBioMedicine 2022;79:103992. [PMID: 35405389 DOI: 10.1016/j.ebiom.2022.103992] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
3 Kain V, Mat Y, Halade GV. Interaction of aging with lipoxygenase deficiency initiates hypersplenism, cardiac dysfunction, and profound leukocyte directed non-resolving inflammation. Geroscience 2021. [PMID: 34932185 DOI: 10.1007/s11357-021-00496-x] [Reference Citation Analysis]
4 Tourki B, Black LM, Kain V, Halade GV. Lipoxygenase inhibitor ML351 dysregulated an innate inflammatory response leading to impaired cardiac repair in acute heart failure. Biomed Pharmacother 2021;139:111574. [PMID: 33862495 DOI: 10.1016/j.biopha.2021.111574] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]